TRVI Valuation
Trevi Therapeutics Inc
$
6.290
- Overview
- Forecast
- Valuation
- Earnings
TRVI Relative Valuation
TRVI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TRVI is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
6.53
P/B
Median3y
2.62
Median5y
2.51
-6.56
FCF Yield
Median3y
-20.43
Median5y
-41.75
Competitors Valuation Multiple
The average P/S ratio for TRVI's competitors is 147.55, providing a benchmark for relative valuation. Trevi Therapeutics Inc Corp (TRVI) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
CANG
Cango Inc
4.560
USD
-1.30%
HBANL
Huntington Bancshares Inc
24.860
USD
+0.04%
CIX
CompX International Inc
25.160
USD
-1.29%
CVEO
Civeo Corp
20.880
USD
-0.10%
NETD
Nabors Energy Transition Corp II
11.050
USD
+0.09%
LPA
Logistic Properties of The Americas
8.320
USD
+18.86%
ZBIO
Zenas Biopharma Inc
11.430
USD
-0.17%
MBX
MBX Biosciences Inc
12.150
USD
-2.88%
BRT
BRT Apartments Corp
15.260
USD
-0.39%
CIVB
Civista Bancshares Inc
22.050
USD
-1.25%
FAQ
Is Trevi Therapeutics Inc (TRVI) currently overvalued or undervalued?
Trevi Therapeutics Inc (TRVI) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Trevi Therapeutics Inc (TRVI) is between to according to relative valuation methord.
What is Trevi Therapeutics Inc (TRVI) fair value?
How does TRVI's valuation metrics compare to the industry average?
What is the current P/B ratio for Trevi Therapeutics Inc (TRVI) as of May 25 2025?
What is the current FCF Yield for Trevi Therapeutics Inc (TRVI) as of May 25 2025?
What is the current Forward P/E ratio for Trevi Therapeutics Inc (TRVI) as of May 25 2025?